New Year Bumper Sale @ Rs. 1 X
StayHappi Cinnarizine Tablet is an allopathic medicine The correct dosage of StayHappi Cinnarizine Tablet depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
StayHappi Cinnarizine Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
Is the use of StayHappi Cinnarizine Tablet safe for pregnant women?
StayHappi Cinnarizine Tablet can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking StayHappi Cinnarizine Tablet right away. Take your doctor's advice before taking it again.
Is the use of StayHappi Cinnarizine Tablet safe during breastfeeding?
StayHappi Cinnarizine Tablet may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking StayHappi Cinnarizine Tablet, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of StayHappi Cinnarizine Tablet.
What is the effect of StayHappi Cinnarizine Tablet on the Kidneys?
StayHappi Cinnarizine Tablet may have mild side effects on the kidneys.
What is the effect of StayHappi Cinnarizine Tablet on the Liver?
StayHappi Cinnarizine Tablet may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of StayHappi Cinnarizine Tablet on the Heart?
StayHappi Cinnarizine Tablet is not harmful for the heart.
StayHappi Cinnarizine Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
If you are suffering from any of the following diseases, you should not take StayHappi Cinnarizine Tablet unless your doctor advises you to do so -
Is this StayHappi Cinnarizine Tablet habit forming or addictive?
Forming a habit of StayHappi Cinnarizine Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the StayHappi Cinnarizine Tablet can make you feel drowsy.
Is it safe?
StayHappi Cinnarizine Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
StayHappi Cinnarizine Tablet is unable to treat or cure mental disorders.
Interaction between Food and StayHappi Cinnarizine Tablet
You can take StayHappi Cinnarizine Tablet with food.
Interaction between Alcohol and StayHappi Cinnarizine Tablet
Consuming StayHappi Cinnarizine Tablet with alcohol can have many serious effects on your body.
Yes, StayHappi Cinnarizine Tablet effectively cure vertigo associated with motion sickness. However, it is best to consult your doctor for the right dose, frequency, and duration for the treatment of vertigo.
Yes, StayHappi Cinnarizine Tablet causes drowsiness. It is a common side effect of this medicine. You are recommended to not drive any vehicle or operate machinery after taking this medicine as it causes drowsiness.
Yes, StayHappi Cinnarizine Tablet is safe to use, if taken in a prescribed amount for a specified time as advised by the doctor. However, few side effects are observed at therapeutic doses like drowsiness, indigestion, and dry mouth.
No, you cannot buy StayHappi Cinnarizine Tablet over-the-counter because it is a prescription drug, without prescription of a healthcare practitioner, you cannot buy it directly from the pharmacy.
No, StayHappi Cinnarizine Tablet does not cause Parkinson's disease. However, precautions must be taken in these patients because its use might worsen their symptoms.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 663-664